Stem Cell Therapeutics Announces Issuance of Third US Patent
26-May-2006 -
Stem Cell Therapeutics Corp. announced that the U.S. Patent and Trademark Office has granted U.S. Patent 7,048,934 to the company's wholly-owned subsidiary, Stem Cell Therapeutics Inc. The patent, entitled "Combined Regulation of Neural Cell Production", protects novel methods of treating ...
Alzheimer's disease
central nervous system
diseases
+7